Skip to main content
Fig. 2 | Clinical Proteomics

Fig. 2

From: O-GlcNAcylation protein disruption by Thiamet G promotes changes on the GBM U87-MG cells secretome molecular signature

Fig. 2

The inhibition of OGA activity increases the number of viable GBM cells in vitro. a–f Optical microscopy in bright field showing cells of the control group and iOGA group during 24 h, 48 h and 72 h of treatment. g Counting of viable cells in Neubauer chamber by trypan blue exclusion after 72 h of treatment; h Quantification of cell viability assay by flow cytometry after 72 h of treatment; i Quantification of cell cycle assay by flow cytometry after 72 h of treatment. N = 3; * p < 0,05; ** p < 0,01; *** p < 0,001

Back to article page